Skip to main content
Peter DeMaria, MD, Oncology, San Antonio, TX

PeterJosephDeMariaMD

Oncology • San Antonio, TX

Clinical Investigator, Phase 1 Clinical Trials at NEXT Oncology

Join to view full profile

Dr. DeMaria is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. DeMaria's full profile

Already have an account?

  • Office

    2829 Babcock Road
    Ste 300
    San Antonio, TX 78229

Summary

  • Peter J. DeMaria, MD is a medical oncologist with a focus on early phase drug development at NEXT Oncology.

    Dr. DeMaria is a graduate of the NCI-FDA Interagency Oncology Task Force, a joint fellowship program with the National Cancer Institute (NCI), National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA). Dr. DeMaria completed an NCI-sponsored combined clinical fellowship in hematology and oncology through the NIH Intramural Research Program. He later served as a medical officer with the Office of Oncologic Diseases, Office of New Drugs, Center for Drug Evaluation and Research, FDA.

    Prior to joining the federal government, he completed residency training in internal medicine and a clinical fellowship in hospice and palliative medicine at Jackson Memorial Hospital. He received his medical degree from the University of Miami Miller School of Medicine and his undergraduate degree in economics from Dartmouth College. With a focus on the development of novel cancer therapies, Dr. DeMaria’s skillset includes clinical trial methodology and analysis, clinical aspects of medical product development, and regulation to facilitate the movement of drugs, biologics, and devices from the basic bench science to commercialization.

    Dr. DeMaria is certified by the American Board of Internal Medicine in medical oncology, internal medicine, and hospice and palliative medicine. He is board eligible in hematology. Active licensure in Texas and Florida.

Education & Training

  • Food and Drug Administration
    Food and Drug AdministrationFellowship, NCI-FDA Interagency Oncology Task Force Fellowship, 2019 - 2020
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hospice and Palliative Medicine, 2016 - 2017
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2013 - 2016
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 2013, MD
  • Dartmouth College
    Dartmouth CollegeB.A., Economics, Cum Laude, 2002 - 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2027
  • TX State Medical License
    TX State Medical License 2024 - 2026
  • DC State Medical License
    DC State Medical License 2018 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Conquer Cancer Merit Award ($1000) American Society of Clinical Oncology (ASCO), 2020
  • NIH Outstanding Academic Achievement Award National Institutes of Health, 2020
  • NCI Quality Improvement Group Award ($500) National Cancer Institute, 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding  
    Cortes JE, Abruzzese E, Cardonick EH, Hernandez-Diaz S, Gutierrez J, Sardegna MS, Torres-Chavez E, Dinatale M, Lerro CC, Gehrke BJ, Shord SS, de Claro RA, Theoret MR, ..., Clinical Cancer Research, 7/5/2024
  • Career options for graduating oncology fellows at the NIH and FDA  
    DeMaria, PJ, Gao, JJ, OncLive, 6/15/2020
  • Giant Malignant Melanomas and their Clinical Implications: Review of Literature and Case Report.  
    Gishen K, DeMaria P, Khanlari M, ChoVega HJ, Feun L, Thaller S, Moller MG, Clinics in surgery, 9/1/2016
  • Join now to see all

Abstracts/Posters

  • A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.
    DeMaria PJ, Lee-Wisdom K, Madan RA, Karzai FH, Donahue RN, Palena C, Jochems C, Floudas CS, Strauss J, Marté JL, Redman JM, Abdul Sater H, Korchin B, Adams T, Silberna..., American Society of Clinical Oncology (ASCO) Annual Meeting, Virtual, 6/4/2021
  • Association of CTNNB1 mutation subtypes with response to systemic therapy in patients with desmoid tumors: a multi-institutional retrospective study
    Nathenson, M, Somaiah, N, Hsu, R, DeMaria, P, Catoe, H, Malik, K, Harris, C, Subhawong, TK, Amini, B, Jagannathan, JP, Braschi-Amirfarzan, M, Sweet, K, Feister, K, Hu,..., Connective Tissue Oncology Society Annual Meeting, Virtual, 11/21/2020
  • A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in...
    DeMaria, PJ, Bilusic, M, Park, D, Heery, CR, Madan, RA, Strauss, J, Donahue, R, Marte, J, Gilbert, M, Steinberg, SM, Schlom, J, and Gulley, JL, ASCO Annual Conference, Virtual, 5/25/2020

Lectures

  • Results with volumetric analysis from a phase 2 clinical trial of a yeast-brachury vaccine (GI-6301) with definitive radiation therapy in locally advanced, unresectabl... 
    Plenary session oral presentation at: International Chordoma Research Workshop (Virtual) - 7/16/2020
  • Targeted Therapies for Acute Leukemia: Safety During Pregnancy/Lactation and Labeling Consistency 
    White Oak, MD - 4/20/2020
  • Hospice and Palliative Care in the United States 
    Croatian Society for Palliative Medicine of the Croatian Medical Association - Vukovar, Croatia - 10/18/2019
  • Join now to see all

Grant Support

  • Rockefeller Grant ($5,000)Nelson A. Rockefeller Center for Public Policy and the Social Sciences2005

Research History

  • Lead Associate Investigator, Center for Cancer Research, National Cancer Institute, National Institutes of HealthNCI Protocol 20-C-0001: Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients with Advanced Cancer (NCT04134312)2020 - 2021
  • Associate Investigator, Center for Cancer Research, National Cancer Institute, National Institutes of HealthNCI Protocol 15-C-0118: A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination with Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma (NCT02383498)2019 - 2020
  • Researcher, Sylvester Comprehensive Cancer CenterCorrelation of CTNNB1 Mutation Status with Chemotherapy Response by MRI in Patients with Desmoid Tumors2015 - 2017
  • Research Assistant, Department of Family Medicine, University of Miami Miller School of Medicine2008 - 2009

Professional Memberships

Other Languages

  • Spanish

External Links

  • LinkedInhttps://www.linkedin.com/in/peter-j-demaria-ba934a48/

Dr. Peter DeMaria, Dr. Peter DeMaria, MD, Dr. P DeMaria, Dr. Peter Joseph DeMaria